Teacher Retirement System of Texas Acquires 11,089 Shares of Cabot Corporation $CBT

Teacher Retirement System of Texas boosted its holdings in Cabot Corporation (NYSE:CBTFree Report) by 134.6% in the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 19,327 shares of the specialty chemicals company’s stock after purchasing an additional 11,089 shares during the quarter. Teacher Retirement System of Texas’ holdings in Cabot were worth $1,470,000 as of its most recent SEC filing.

A number of other institutional investors have also added to or reduced their stakes in the stock. Penserra Capital Management LLC raised its holdings in shares of Cabot by 65.7% during the 2nd quarter. Penserra Capital Management LLC now owns 6,609 shares of the specialty chemicals company’s stock worth $495,000 after acquiring an additional 2,620 shares in the last quarter. First Citizens Bank & Trust Co. grew its holdings in shares of Cabot by 144.4% in the second quarter. First Citizens Bank & Trust Co. now owns 14,352 shares of the specialty chemicals company’s stock valued at $1,076,000 after purchasing an additional 8,479 shares in the last quarter. American Century Companies Inc. increased its position in Cabot by 11.1% in the second quarter. American Century Companies Inc. now owns 1,664,728 shares of the specialty chemicals company’s stock worth $124,855,000 after purchasing an additional 166,460 shares during the last quarter. Sequoia Financial Advisors LLC purchased a new stake in Cabot during the second quarter valued at $436,000. Finally, Paradiem LLC lifted its position in Cabot by 65.5% during the third quarter. Paradiem LLC now owns 149,097 shares of the specialty chemicals company’s stock valued at $11,339,000 after purchasing an additional 59,030 shares during the last quarter. 93.18% of the stock is owned by hedge funds and other institutional investors.

Cabot Trading Down 0.0%

Shares of NYSE CBT opened at $72.19 on Friday. Cabot Corporation has a fifty-two week low of $58.33 and a fifty-two week high of $89.16. The company has a debt-to-equity ratio of 0.50, a quick ratio of 1.08 and a current ratio of 1.61. The company has a market cap of $3.82 billion, a price-to-earnings ratio of 12.01, a PEG ratio of 3.78 and a beta of 0.89. The business’s 50 day moving average price is $68.13 and its 200-day moving average price is $71.69.

Cabot (NYSE:CBTGet Free Report) last announced its quarterly earnings data on Monday, November 3rd. The specialty chemicals company reported $1.70 EPS for the quarter, missing the consensus estimate of $1.72 by ($0.02). Cabot had a net margin of 8.91% and a return on equity of 24.55%. The business had revenue of $899.00 million during the quarter, compared to the consensus estimate of $967.02 million. During the same period last year, the company earned $1.80 EPS. The business’s revenue was down 10.2% compared to the same quarter last year. Cabot has set its FY 2026 guidance at 6.000-7.00 EPS. On average, sell-side analysts expect that Cabot Corporation will post 7.57 earnings per share for the current year.

Cabot Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Friday, December 12th. Investors of record on Friday, November 28th were paid a $0.45 dividend. This represents a $1.80 annualized dividend and a yield of 2.5%. The ex-dividend date of this dividend was Friday, November 28th. Cabot’s dividend payout ratio (DPR) is currently 29.95%.

Wall Street Analysts Forecast Growth

CBT has been the subject of a number of recent research reports. UBS Group lifted their price objective on shares of Cabot from $65.00 to $74.00 and gave the stock a “neutral” rating in a research note on Monday, January 12th. Weiss Ratings reiterated a “hold (c-)” rating on shares of Cabot in a research report on Monday, December 29th. Jefferies Financial Group reissued a “buy” rating and set a $81.00 price objective on shares of Cabot in a research note on Thursday, January 8th. Zacks Research raised Cabot from a “strong sell” rating to a “hold” rating in a research note on Tuesday, January 27th. Finally, JPMorgan Chase & Co. dropped their target price on Cabot from $75.00 to $54.00 and set an “underweight” rating for the company in a report on Friday, November 28th. Two research analysts have rated the stock with a Buy rating, three have assigned a Hold rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat.com, the stock currently has a consensus rating of “Hold” and an average price target of $72.25.

View Our Latest Research Report on CBT

Cabot Company Profile

(Free Report)

Cabot Corporation is a global specialty chemicals and performance materials company headquartered in Boston, Massachusetts. Founded in 1882 by Godfrey Lowell Cabot, the company has grown into a diversified manufacturer with operations across North America, Europe, Asia and Latin America. Cabot serves a wide range of end markets, including automotive, industrial, energy, and consumer products, supplying essential ingredients that enhance performance, durability and functionality.

The company operates two primary segments: Reinforcement Materials and Performance Materials.

See Also

Want to see what other hedge funds are holding CBT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cabot Corporation (NYSE:CBTFree Report).

Institutional Ownership by Quarter for Cabot (NYSE:CBT)

Receive News & Ratings for Cabot Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cabot and related companies with MarketBeat.com's FREE daily email newsletter.